- Home
- SPTN vs PRTA Comparison
SPTN vs PRTA Comparison
Compare SPTN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- PRTA
- Stock Information
- Founded
- SPTN 1917
- PRTA 2012
- Country
- SPTN United States
- PRTA Ireland
- Employees
- SPTN N/A
- PRTA N/A
- Industry
- SPTN Food Distributors
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- PRTA Health Care
- Exchange
- SPTN Nasdaq
- PRTA Nasdaq
- Market Cap
- SPTN 596.4M
- PRTA 809.8M
- IPO Year
- SPTN N/A
- PRTA N/A
- Fundamental
- Price
- SPTN $26.60
- PRTA $6.40
- Analyst Decision
- SPTN Hold
- PRTA Buy
- Analyst Count
- SPTN 1
- PRTA 9
- Target Price
- SPTN $26.90
- PRTA $27.67
- AVG Volume (30 Days)
- SPTN 1.3M
- PRTA 1.8M
- Earning Date
- SPTN 08-14-2025
- PRTA 08-07-2025
- Dividend Yield
- SPTN 3.27%
- PRTA N/A
- EPS Growth
- SPTN N/A
- PRTA N/A
- EPS
- SPTN N/A
- PRTA N/A
- Revenue
- SPTN $9,652,685,000.00
- PRTA $137,935,000.00
- Revenue This Year
- SPTN $6.00
- PRTA N/A
- Revenue Next Year
- SPTN N/A
- PRTA $119.20
- P/E Ratio
- SPTN N/A
- PRTA N/A
- Revenue Growth
- SPTN 0.26
- PRTA 54.55
- 52 Week Low
- SPTN $17.30
- PRTA $4.32
- 52 Week High
- SPTN $26.65
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- SPTN 78.13
- PRTA 54.04
- Support Level
- SPTN $26.37
- PRTA $5.96
- Resistance Level
- SPTN $26.56
- PRTA $6.59
- Average True Range (ATR)
- SPTN 0.29
- PRTA 0.40
- MACD
- SPTN 0.60
- PRTA 0.18
- Stochastic Oscillator
- SPTN 99.45
- PRTA 79.56
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).